Lisata Therapeutics LSTA
NASDAQ LSTA
$1.49 +0.05 (+3.47%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lisata Therapeutics (LSTA) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Lisata Therapeutics (LSTA) reported Liabilities and Shareholders Equity of $11.03 million for Q2 2026, down 56.2% from $25.16 million a year earlier and down 21.6% from the prior quarter.

Analysis

Lisata Therapeutics (LSTA) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Lisata Therapeutics posted Liabilities and Shareholders Equity of $17.74 million, down 49.3% from FY2024.

  • Liabilities and Shareholders Equity has declined for four consecutive years, with a five-year compound annual growth rate of -13.2% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $35 million in FY2024 (-36.0%), $54.69 million in FY2023 (-25.1%), $73.03 million in FY2022 (-24.7%) and $97.01 million in FY2021 (+169.5%).
  • The Q2 2026 figure ranks as the lowest quarterly Liabilities and Shareholders Equity in data going back to Q4 2010.
  • Year over year, Liabilities and Shareholders Equity has now declined in each of the last 18 quarters, with an average decline of 43.9% over the last eight quarters.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2021 (growth of 169.5%); the low point was Q2 2026 (a decline of 56.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $14.06 million (Q1 2026), $17.74 million (Q4 2025) and $21.76 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Lisata Therapeutics 13.13 Mn 12.88 Mn - 11.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.03 Mn
Mar 31, 2026 14.06 Mn
Dec 31, 2025 17.74 Mn
Sep 30, 2025 21.76 Mn
Jun 30, 2025 25.16 Mn
Mar 31, 2025 28.98 Mn
Dec 31, 2024 35.00 Mn
Sep 30, 2024 38.20 Mn
Jun 30, 2024 42.57 Mn
Mar 31, 2024 48.24 Mn
Dec 31, 2023 54.69 Mn
Sep 30, 2023 58.09 Mn
Jun 30, 2023 62.37 Mn
Mar 31, 2023 66.33 Mn
Dec 31, 2022 73.03 Mn
Sep 30, 2022 78.53 Mn
Jun 30, 2022 85.88 Mn
Mar 31, 2022 91.46 Mn
Dec 31, 2021 97.01 Mn
Sep 30, 2021 102.54 Mn
API Access

Lisata Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=LSTA&period=max&api_key=YOUR_API_KEY